BioSpace News Archive

Poseidon exposing its unique PLUG & PLAY pharma ocean-freight model in London

After a vigorous inaugural year, the wave-parting Poseidon pharmaceutical ocean-freight network will be laying bare its unique “PLUG & PLAY” operating model at the IQPC Temperature Controlled Logistics (TCL) Conference at Twickenham Stadium, London, from 28th to 31st January 2019.

January 15, 2019
·
4 min read
Business

UNH Reaches Top Tier of Carnegie Classification for Research Universities

The University of New Hampshire has risen to the top echelon of research universities in the country as designated by the Carnegie Classification of Institutions of Higher Education and is now among the 130 doctoral-granting universities in the “very high research activity,” or R1, category

January 15, 2019
·
2 min read
Business

MDxHealth (R): MDxHealth Provides Business Update January 14, 2019

MDxHealth SA today issued a preliminary update on its 2018 financial results.

January 15, 2019
·
3 min read
Job Trends

Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated

Study underscores importance of sharing risks with patients considering lung cancer screening

January 15, 2019
·
5 min read
Genetown

New LabElite® DeCapper SL Expands Hamilton Storage LabElite Product Family

Hamilton Storage introduces a new member of the LabElite® product family with the launch of the LabElite DeCapper SL

January 15, 2019
·
2 min read
Drug Development

Merck’s Keytruda Cuts Death Risk by 31% in Esophageal Cancer

Merck’s Keytruda just keeps on proving its value to the company and patients. The company released data from KEYNOTE-181, a Phase III trial of Keytruda as a monotherapy for the second-line treatment of advanced or metastatic esophageal or esophagogastric junction carcinoma.

January 15, 2019
·
3 min read
·
Mark Terry
Policy

House Oversight Committee Takes on Pharma Industry

It didn’t take long for the new leadership structure in the U.S. House of Representatives to take on the pharmaceutical industry. On Monday, the House Committee on Oversight and Reform launched an investigation into prescription drug pricing practices.

January 15, 2019
·
2 min read
·
Alex Keown
Policy

Wave Life Sciences Enters FDA’s Clinical Trial Pilot Program to Develop DMD Drug

Wave Life Sciences is working to get its nucleic acid treatment, suvodirsen, for Duchenne muscular dystrophy (DMD) approved. DMD is a rare muscle-wasting disease that affects mostly boys, about 15,000 in the U.S.

January 15, 2019
·
3 min read
·
Mark Terry
Drug Development

Brain-Eating Amoeba Infections Are Rare, but Deadly—Research Is Working on a Cure

The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.

January 15, 2019
·
4 min read
·
Mark Terry
FDA

Despite Government Shutdown, Exelixis Snags FDA Approval for HCC Drug Cabometyx

The FDA approved Cabometyx based on the Phase III CELESTIAL trial that showed the drug provided a statistically significant and clinically meaningful improvement in median overall survival.

January 15, 2019
·
2 min read
·
Alex Keown